Prediction of selective estrogen receptor beta agonist using open data and machine learning approach
暂无分享,去创建一个
Ai-qin Niu | Liang-jun Xie | Hui Wang | Bing Zhu | Sheng-qi Wang | A. Niu | B. Zhu | Hui Wang | Sheng Wang | Liang-jun Xie
[1] Margaret Warner,et al. Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.
[2] B. Katzenellenbogen,et al. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[3] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[4] R. Girgert,et al. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells. , 2015, International journal of oncology.
[5] Hongmao Sun. A naive bayes classifier for prediction of multidrug resistance reversal activity on the basis of atom typing. , 2005, Journal of medicinal chemistry.
[6] L. Hartmann,et al. Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. , 2003, The New England journal of medicine.
[7] Zhaohui J. Cai,et al. Pretreatment data is highly predictive of liver chemistry signals in clinical trials , 2012, Drug design, development and therapy.
[8] A. Brown,et al. Sulfonamides as selective oestrogen receptor β agonists. , 2011, Bioorganic & medicinal chemistry letters.
[9] Weida Tong,et al. Development and Validation of Decision Forest Model for Estrogen Receptor Binding Prediction of Chemicals Using Large Data Sets. , 2015, Chemical research in toxicology.
[10] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[11] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.
[12] R. Houtman,et al. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[13] Feixiong Cheng,et al. In silico Prediction of Chemical Ames Mutagenicity , 2012, J. Chem. Inf. Model..
[14] A. Franchitto,et al. An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[15] Richard S. Judson,et al. Binary Classification of a Large Collection of Environmental Chemicals from Estrogen Receptor Assays by Quantitative Structure-Activity Relationship and Machine Learning Methods , 2013, J. Chem. Inf. Model..
[16] Lei Chen,et al. ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. , 2011, Molecular pharmaceutics.
[17] V. Jordan,et al. Send Orders of Reprints at Reprints@benthamscience.net the Discovery and Development of Selective Estrogen Receptor Modulators (serms) for Clinical Practice the Biological Basis of Serm Action: Target Tissue Specific Actions , 2022 .
[18] J. Katzenellenbogen,et al. Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential , 2014, Steroids.
[19] Tingjun Hou,et al. ADME evaluation in drug discovery , 2002, Journal of molecular modeling.
[20] K. Dhingra. Selective Estrogen Receptor Modulation: The Search for an Ideal Hormonal Therapy for Breast Cancer , 2001, Cancer investigation.
[21] B. Katzenellenbogen,et al. Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model , 2015, Journal of medicinal chemistry.
[22] Lei Chen,et al. Selective ligands of estrogen receptor β discovered using pharmacophore mapping and structure-based virtual screening , 2014, Acta Pharmacologica Sinica.
[23] Robert P. Sheridan,et al. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..
[24] Kerenaftali Klein,et al. A Bayesian Modelling Approach with Balancing Informative Prior for Analysing Imbalanced Data , 2016, PloS one.
[25] CHUN WEI YAP,et al. PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..
[26] Lei Yang,et al. Classification of Cytochrome P450 Inhibitors and Noninhibitors Using Combined Classifiers , 2011, J. Chem. Inf. Model..
[27] M. W. B. Trotter,et al. Support vector machines for drug discovery , 2007 .
[28] Konrad F. Koehler,et al. Development of subtype-selective oestrogen receptor-based therapeutics , 2011, Nature Reviews Drug Discovery.
[29] K. Dahlman-Wright,et al. Estrogen receptor alpha and beta in health and disease. , 2015, Best practice & research. Clinical endocrinology & metabolism.
[30] Swagatam Das,et al. Near-Bayesian Support Vector Machines for imbalanced data classification with equal or unequal misclassification costs , 2015, Neural Networks.
[31] P. Fuller,et al. The importance of ERbeta signalling in the ovary. , 2010, The Journal of endocrinology.
[32] S. Gapstur,et al. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. , 2001, Journal of the National Cancer Institute.
[33] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[34] Marco Macchia,et al. Estrogen receptor β ligands: Recent advances and biomedical applications , 2011, Medicinal research reviews.
[35] A. Taylor,et al. Immunolocalisation of oestrogen receptor beta in human tissues. , 2000, Journal of molecular endocrinology.